Publications
342
Citations
6,359
Est. group size
—
Recurring co-author estimate
Active years
28
Publishing since 1999
Typically publishes in teams of ~9 · 6% small-team papers (≤3 authors) · across 73 venues
- 26-A-10897-ACC IMPACT OF CATHETER ABLATION VERSUS ANTI-ARRHYTHMIC DRUGS ON ALL-CAUSE MORTALITY IN ATRIAL FIBRILLATION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Journal of the American College of Cardiology · 2026
- Restraint of cancer cell plasticity by spatial homotypic clustering
Cancer Cell · 2025
- Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma models
Journal of Clinical Investigation · 2025
- Neurosurgical Approach to Neurocysticercosis in Adults: A Comprehensive Systematic Review of Clinical and Imaging Insights
Neurosurgery · 2025
- Polyamine acetylation mediates crosstalk between cancer cells and myeloid cells to promote mesenchymal/plurimetabolic states in glioblastoma
Neuro-Oncology · 2025
- Current trends in reoperation for recurrent glioblastoma: a meta-analysis (2007–2023)
Journal of Neuro-Oncology · 2025
- Translating Venom to Medicine: A Comprehensive Review on the Role of Chlorotoxin in Glioblastoma Diagnosis and Therapy
Molecular Cancer Therapeutics · 2025
- Unraveling the impact of Anabaena azotica and Nostoc flagelliforme on wheat performance under saline-alkali soil and combined abiotic stresses
Algal Research · 2025
- The impact of perilesional heatsink structures on ablation volumes and symmetry in laser interstitial thermal therapy for the treatment of primary central nervous system tumors
Journal of neurosurgery · 2025
- Targeting cell cycle arrest in breast cancer by phytochemicals from Caryto urens L. fruit ethyl acetate fraction: in silico and in vitro validation
Journal of Ayurveda and Integrative Medicine · 2025
- The Role of Viruses in the Glioma Tumor Microenvironment: Immunosuppressors or Primers for Anti-Tumor Immunity?
Cancers · 2025
- Synergistic Treatment with Antiretrovirals and Laser Interstitial Thermal ThErapy (STARLITE) for unresectable glioblastoma: A phase 1 study protocol
PLoS ONE · 2025
- PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide
Research Square · 2025
- DDDR-02. PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide
Neuro-Oncology · 2025
- Concomitant Convection Enhanced Delivery and Craniotomy for Retroviral Gene Therapy Against Multifocal Recurrent Glioblastoma: 2-Dimensional Operative Video
Operative Neurosurgery · 2025
- World Neurosurgery×34
- Neurosurgery×29
- Neuro-Oncology×22
- Journal of Neuro-Oncology×19
- Foot & Ankle Orthopaedics×19
- Mark Damante
Medicine · The Ohio State University
- Angela M. Richardson
Medicine · Indiana University
- Tiffany R. Hodges
Medicine · University of Michigan
- Joshua D. Palmer
Medicine · The Ohio State University
- Mitesh V. Shah
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile